Concerta

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

CognitionTherapeutics

85 competitors in Cognition

#DrugCompanyPhaseTrials

1

Xarelto

WWim Janssens

Approved

12

Ambien

PPurdue Pharma LP

Approved

13

Prometrium

Ferring

Approved

14

Neurontin

VViatris Specialty LLC

Approved

15

Osmitrol

BB. Braun Medical Inc.

Approved

—6

Zanaflex

LLegacy Health System

Approved

—7

Namenda

AbbVie

Phase 3

38

Nuplazid

AACADIA Pharmaceuticals Inc.

Phase 2

19

Remimazolam Tosilate

FFujian Shengdi Pharmaceutical Co., Ltd.

Phase 3

110

Psilocybin

COMPASS Pathways

Phase 2

1Show 44 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Children2 trials

Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD

Completed·NNoven Therapeutics·Phase 2·NCT00151970·128 enrolled

Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD

Completed·UUniversity of Maryland, College Park·Phase 4·NCT00318981·40 enrolled

Safety and Efficacy2 trials

Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

Completed·NNoven Therapeutics·Phase 3·NCT00444574·282 enrolled

A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

Completed·Merck & Co.·Phase 2·NCT00475735·72 enrolled

Attention Deficit Hyperactivity Disorder2 trials

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Terminated·PPurdue Pharma LP·Phase 4·NCT04507204·267 enrolled

CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults

Completed·Johnson & Johnson·Phase 3·NCT00246207·32 enrolled

SMA1 trial

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

Completed·Johnson & Johnson·Phase 1·NCT01118702·30 enrolled

Biomarkers1 trial

Biomarkers of ADHD Treatment Response

Completed·—·Phase 1·NCT05650775·16 enrolled

6 more indications

Interaction1 trial

A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers

Completed·Takeda·Phase 1·NCT00901576·38 enrolled

Therapeutics1 trial

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

Recruiting·—·N/A·NCT06369714·210 enrolled

Memory1 trial

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Terminated·UUniversity of South Florida·Phase 2·NCT00069927·12 enrolled

Cognition1 trial

Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome

Completed·UUniversity of Geneva, Switzerland·N/A·NCT04647500·45 enrolled

ADHD1 trial

Benefits of In-prison OROS-methylphenidate vs. Placebo Treatment in Detained People With Attention-deficit/Hyperactivity Disorder: A Randomized Controlled Trial

Recruiting·SStéphanie Baggio·Phase 3·NCT05842330·150 enrolled

Unspecified1 trial

Concerta (Methylphenidate) -To-Generic Switch Study

Completed·Johnson & Johnson··NCT02730572·1,464 enrolled

Details

Drug Info

Related News